Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to determine whether HIV patients on Atazanavir who have Hyperbilirubinemia have different outcomes from those without Hyperbilirubinemia.
Epistemonikos ID: f923ed88947fe8dd5d2fb4f5aa4b582041972157
First added on: May 12, 2024